vedolizumab
takeda
['vedolizumab', ' vedo', 'vedo', 'crohn']
 fascinating talk on the use of vedolizumab to prevent post-operative recurrence in crohn s disease. audience member comment clinical symptoms are meaningless in this setting and chairperson paul moayyedi challenged these matter to our patients the most! 
Professor of evidence synthesis and systematic review at UCLAN, Consultant paediatrician Blackpool Hospital, Editor Cochrane IBD and BEME collaboration